IPOTRXB
Should You Buy the TRex Bio IPO? Here's the Setup
TRex Bio, Inc. (NASDAQ: TRXB) is expected to list on 2026-10-09 in a $14.00 to $16.00 IPO. The company is offering 8,333,334 shares as it tries to fund a clinical-stage immunology platform built around Treg biology. Bull case: strong strategic backing from Lilly, Pfizer, and J&J plus a differentiated science story. Bear case: no product revenue yet, ongoing losses, and a long road from clinical data to commercialization.
Oct 7, 20265 MIN